|
|
||||||||
|
|
|||||||||
|
|
Technologist AbstractsTechnologist Posters |
1 UGent-IBBT, Gent, Belgium; 2 UGent, Gent, Belgium
2110
Objectives: Small animal imaging studies are preferably acquired by nuclear medicine cameras tailored for small animals. However this dedicated small animal apparatus is not always mandatory. The presented study shows a follow-up of rats which were inoculated with tumour cells. This was done to have an idea of the tumour lifespan in order to get a correct timing for treatment with paclitaxel which is a drug used for intracavitary chemotherapy in rats with peritoneal carcinomatosis. The purpose of this study was to evaluate the image quality achievable with available clinical human equipment.
Methods: The tumour growth of three rats was followed by the administration of 18F-FDG. PET/CT imaging was performed 5 times with 3-4 days intervals on a human scanner. The injected activity ranged from 400 to 1300 µCi and emission times varied from 15 to 22 min and data was therefore corrected with a scaling factor. To visualize the changes over time we created a virtual slice presenting maximum values along the axis perpendicular to the coronal plane. For quantitative analysis we first used a moving average filter to reduce the noise. Regions of interest (ROI)were created around the heart and the tumour and the ratios of the maxima of these ROIs were calculated. A knee RF-coil was used in a human MR to measure the size of the tumours (T2, ±15 min). The anaesthesia included isoflurane during PET/CT imaging and xylazine was used in combination with ketamine prior to MR scanning.
Results: We were able to pinpoint the stage of tumour signal decrease. Sensitivity, spatial resolution and acquisition times were suboptimal but acceptable.
Conclusions: This study showed that a small animal scanner is not always mandatory. We could clearly see the signal and volume decrease in a rat tumour staging experiment on a human PET/CT and MR respectively.
| ||||||||||||||||||||||||||||||||||||||